FinnAust Mining’s Roderick McIllree discusses his new position as MD, the acquisition of Bluejay Mining Limited and growth strategy in this exclusive interview with DirectorsTalk
Surface Transforms’ David Bundred discusses increased revenues, furnace problems, game-changing contracts and increasing capacity in this exclusive interview with DirectorsTalk
Ilika’s Graeme Purdy discusses the latest Trading and Operational update and their one square millimetre batteries in this exclusive interview with DirectorsTalk
OptiBioTix Health’s Stephen O’Hara discusses the further fund raise of £2.2 million, what these funds will be used for and the opportunities in skin health in this exclusive interview with DirectorsTalk
Ariana Resources’ Dr Kerim Sener discusses the drilling results at the Arzu South Red Rabbit project and what they mean for the business, the depreciating gold price and the expected revenues from the Red Rabbit project in this exclusive interview with DirectorsTalk
Motif Bio’s Dr. Graham Lumsden discusses the fixed 80mg dose for the Iclaprim Phase III clinical trials in this exclusive interview with DirectorsTalk
Rare Earth Minerals’ Kiran Mozaria discusses the increased 337% of Indicated Mineral Resource and Bacanora Minerals’ funding in this exclusive interview with DirectorsTalk
Feedback’s Dr Balaji Ganeshan discusses the Memorandum of Understanding with Alliance Medical Group in this exclusive interview with DirectorsTalk
NetDimensions’ Matthew Chaloner discusses Morses Club and how it fits into the overall sales growth strategy, high consequence industries, future growth for the company and their £7.2 million successful share placing in this exclusive interview with DirectorsTalk
Strat Aero’s Tony Dunleavy discusses the risk of toy drones and what the industry can do to minimise those risks in this exclusive interview with DirectorsTalk
© 2025 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
